Yang Xun

825 total citations
38 papers, 499 citations indexed

About

Yang Xun is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Yang Xun has authored 38 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Yang Xun's work include Kidney Stones and Urolithiasis Treatments (11 papers), Pediatric Urology and Nephrology Studies (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Yang Xun is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (11 papers), Pediatric Urology and Nephrology Studies (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Yang Xun collaborates with scholars based in China, United States and United Kingdom. Yang Xun's co-authors include Hua You, Hua Yang, Bożena Kamińska, Shaogang Wang, Mary M. Zutter, Anping Yang, Yuanyuan Yang, Fang Liu, Qi‐Dong Xia and Jin‐Zhou Xu and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Experimental Cell Research.

In The Last Decade

Yang Xun

35 papers receiving 489 citations

Peers

Yang Xun
Tobias Engl Germany
Joo Hyoung Lee United States
Shawna M. Pyott United States
H. Roché France
Nobuyasu Takahashi Japan
Narges Seyfizadeh Iran
Jaris Valencia Spain
Brile Chung United States
Tobias Engl Germany
Yang Xun
Citations per year, relative to Yang Xun Yang Xun (= 1×) peers Tobias Engl

Countries citing papers authored by Yang Xun

Since Specialization
Citations

This map shows the geographic impact of Yang Xun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Xun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Xun more than expected).

Fields of papers citing papers by Yang Xun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Xun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Xun. The network helps show where Yang Xun may publish in the future.

Co-authorship network of co-authors of Yang Xun

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Xun. A scholar is included among the top collaborators of Yang Xun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Xun. Yang Xun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xun, Yang, Jun Yan, Yumeng Wang, et al.. (2025). Succinate supplementation alleviates liver cancer by inhibiting the FN1/SQLE axis-mediated cholesterol biosynthesis. iScience. 28(2). 111731–111731. 1 indexed citations
2.
Yang, Hua, Yang Xun, Hongtao Wang, et al.. (2024). A simplified and robust risk stratification model for stem cell transplantation in pediatric acute myeloid leukemia. Cell Reports Medicine. 5(10). 101762–101762. 2 indexed citations
3.
Yan, Jun, Jianwen Xu, Yang Xun, et al.. (2024). Delactylation diminished the growth inhibitory role of CA3 by restoring DUOX2 expression in hepatocellular carcinoma. Experimental Cell Research. 444(2). 114392–114392.
4.
Li, Xianmiao, et al.. (2024). Ferroptosis and its emerging role in kidney stone formation. Molecular Biology Reports. 51(1). 314–314. 5 indexed citations
5.
6.
Li, Xianmiao, et al.. (2024). Engineered microorganisms: A new direction in kidney stone prevention and treatment. Synthetic and Systems Biotechnology. 9(2). 294–303. 9 indexed citations
7.
Yang, Yuanyuan, et al.. (2023). Exosome-mediated crosstalk between epithelial cells amplifies the cell injury cascade in CaOx stone formation. Journal of Biological Engineering. 17(1). 16–16. 9 indexed citations
8.
Yang, Hua, Yang Xun, Chao Ke, Kensuke Tateishi, & Hua You. (2023). Extranodal lymphoma: pathogenesis, diagnosis and treatment. Molecular Biomedicine. 4(1). 29–29. 1 indexed citations
9.
Xu, Jin‐Zhou, Jian‐Xuan Sun, Wenjie Wang, et al.. (2023). Interconnections between urolithiasis and oral health: a cross-sectional and bidirectional Mendelian randomization study. Frontiers in Medicine. 10. 1174502–1174502. 1 indexed citations
10.
Liu, Xiaofan, Ying Peng, Zhe Chen, et al.. (2023). Impact of non-pharmaceutical interventions during COVID-19 on future influenza trends in Mainland China. BMC Infectious Diseases. 23(1). 632–632. 9 indexed citations
11.
Yang, Yuanyuan, Yang Xun, Chen‐Qian Liu, et al.. (2022). Characterization of the Lipid Metabolism in Bladder Cancer to Guide Clinical Therapy. Journal of Oncology. 2022. 1–12. 10 indexed citations
12.
Yang, Yuanyuan, et al.. (2022). The renal pelvis urobiome in the unilateral kidney stone patients revealed by 2bRAD-M. Journal of Translational Medicine. 20(1). 431–431. 21 indexed citations
13.
14.
Yang, Yuanyuan, et al.. (2022). CAV1 alleviated CaOx stones formation via suppressing autophagy-dependent ferroptosis. PeerJ. 10. e14033–e14033. 16 indexed citations
15.
Yang, Yuanyuan, Qing Wang, Yang Xun, Cong Li, & Shaogang Wang. (2022). The Preliminary Exploration of What Role miRNAs Derived From Urinary Exosomes Play in Kidney Stone Formation. Urology. 166. 104–110. 15 indexed citations
16.
Hu, Wei, et al.. (2021). High-grade fetal adenocarcinoma of the lung with abnormal expression of alpha-fetoprotein in a female patient. Medicine. 100(7). e24634–e24634. 3 indexed citations
17.
Yang, Hua, et al.. (2021). BRD4: An emerging prospective therapeutic target in glioma. Molecular Therapy — Oncolytics. 21. 1–14. 36 indexed citations
18.
Li, Wenxing, Shaoxing Dai, Sanqi An, et al.. (2021). Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma. Aging. 13(8). 11833–11859. 4 indexed citations
19.
Xun, Yang, Hua Yang, Bożena Kamińska, & Hua You. (2021). Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma. Journal of Hematology & Oncology. 14(1). 176–176. 90 indexed citations
20.
Xun, Yang, et al.. (2020). Effectiveness and safety of four tract dilation methods of percutaneous nephrolithotomy: A meta‑analysis. Experimental and Therapeutic Medicine. 19(4). 2661–2671. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tobias Engl Breakdown of academic impact, for papers by Joo Hyoung Lee Breakdown of academic impact, for papers by Shawna M. Pyott Breakdown of academic impact, for papers by H. Roché Breakdown of academic impact, for papers by Nobuyasu Takahashi Breakdown of academic impact, for papers by Narges Seyfizadeh Breakdown of academic impact, for papers by Jaris Valencia Breakdown of academic impact, for papers by Brile Chung
Rankless by CCL
2026